发明名称 ANTIBODIES AGAINST FCRN AND USE THEREOF
摘要 This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoinmune disorders. See Fig. 36. WO 2009/131702 PCT/US2009/002536 - (a, z) ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTS - (a, z) GVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKK - (f) ----------------------------------------------- - (a, z) VEIPKS...T HTPPCAPELLGGPSVFLFPPKPKDTLMISRT PEVTCVVV - (a, z) D - (a, z) LN G KEYKCKVSNiKALPAVI FKITI SKAKGQPREPQVYTLPPSPREPQVYT - (a,z) LPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLD - (f)------E-M--------------------------------------- - (a,z) SDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK* - ----------------------------------- ~---~~~~ (a, z) (SEQ ID NO: 115) (f) (SEQ ID NO: 116) SUBSTITUTE SHEET (RULE 26)
申请公布号 AU2015200004(B2) 申请公布日期 2017.02.16
申请号 AU20150200004 申请日期 2015.01.02
申请人 Dyax Corp.;Biogen Hemophilia Inc. 发明人 Tenhoor, Christopher;Muruganandam, Arumugam;Ladner, Robert Charles;Wood, Clive;Bitonti, Alan J.;Stattel, James;McDonnell, Kevin;Liu, Liming;Dumont, Jennifer;Sato, Aaron
分类号 C07K16/28;A61P37/00 主分类号 C07K16/28
代理机构 代理人
主权项
地址
您可能感兴趣的专利